Sangamo Therapeutics Inc (NASDAQ:SGMO) has been in a consolidation phase in the past two sessions and if the stock is able to move past the strong resistance of 18.64 with good volumes, then it will mean higher levels for the stock. The relative strength line is exhibiting a small negative divergence, which is usually a bearish sign, but in this particular case...
Following on strong momentum after Novartis deal, Sangamo Therapeutics with strong open that looks set to breakout the stock from a long sustained downtrend
I'm betting that SGMO will "fly like a duck".
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.
Shooting star. Failed test of resistance. Time to short!!!
All, This is a GREAT stock that has an extremely clear bottom and only $7 which means options and just buy and selling is easy. Right now it is extremely obvious. Buy in around $4 to $4.75 UNLESS it breaks this upper resistance, but even if it does there are some resistance levels $9-$11 range. So I would be careful if you are bullish where it is at now.
The stock is still in early stage of the upward recovery trajectory and has managed to overcome its purple resistance level at $8.70. Mid-term resistance at $9.95 observed,while stronger resistance at $10.70.
Look for sustained rally upwards from 50 day average, powerfull buy signal could be triggered and could move the stock closer to its consensus price target of $13.50 www.smarteranalyst.com NASDAQ:SGMO investor.sangamo.com investor.sangamo.com
buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it buy it